Chris’s practice focuses exclusively on the representation of clients in the life sciences industries. In addition to management of a wide variety of intellectual property matters, Chris specializes in complex technology transactions, including co-development and partnering agreements, complex licensing arrangements and mergers and acquisitions – as well as technical and legal due diligence related to the same. His fundraising experience includes venture capital, private equity, and debt investments.
Chris is the former General Counsel of Alba Therapeutics, where he also served as interim VP of Drug Discovery Operations. He currently serves as outside General Counsel or outside Chief Intellectual Property Counsel to a number of small and mid-sized diagnostic, pharmaceutical, medical device and biotechnology companies. In addition, Chris is the founder and former managing member of FirstStage Bioventures, LLC, and was co-founder of Seguro Surgical and EncephRx Pharmaceuticals.